Diffusion-weighted MR imaging in pancreatic ductal adenocarcinoma: prediction of next-generation sequencing-based tumor cellularity and prognosis after surgical resection
- 18 June 2021
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 46 (10) , 4787-4799
Abstract
Purpose To identify features on preoperative MR imaging with diffusion-weighted imaging (DWI) for predicting next-generation sequencing (NGS)-based tumor cellularity and patient outcome after surgical resection of pancreatic ductal adenocarcinoma (PDAC). Methods This retrospective study included 105 patients with surgically resected PDAC who underwent preoperative MR imaging with DWI. Tumor cellularity was measured using molecular techniques and bioinformatics methods. Clinico-pathologic findings including tumor T stage for predicting disease-free survival (DFS) and overall survival (OS) were identified using Cox proportional hazards model. Important MR imaging findings including apparent diffusion coefficient (ADC) value of PDAC and modified ADC value (the ratio of the ADC value of PDAC to the ADC value of the spleen) for predicting higher tumor cellularity (≥ 30%) and poor prognosis were also identified. Results The median DFS and OS were 12.0 months [95% confidence interval (CI), 8.0–17.0] and 22.0 months (95% CI, 18.0–29.0), respectively. Higher T stage (T3/4) [hazard ratio (HR), 7.720, (95% CI 1.072, 55.612); p = 0.048] and higher tumor cellularity [HR, 1.599 (95% CI, 1.003–2.548); p = 0.048] were significantly associated with worse DFS. Among MR imaging features, the modified ADC value was significantly associated with tumor cellularity [odds ratio, 0.068 (95% CI, 0.012–0.372); p = 0.002], and PDAC with lower modified ADC value [≤ 1.40 (cutoff value)] showed significantly shorter median DFS than PDAC with higher modified ADC value [8 months (95% CI, 4–12) vs. 16 months (95% CI, 10–29); HR, 1.713 (95% CI, 1.073–2.735), log-rank p = 0.024]. Conclusion Higher NGS-based tumor cellularity may be a negative prognostic factor in pancreatic cancer after resection, and modified ADC value derived from DWI could be helpful in predicting tumor cellularity and patient surgical outcome with regard to recurrence. Graphic abstractKeywords
This publication has 28 references indexed in Scilit:
- Pancreatic cancer: Lack of association between apparent diffusion coefficient values and adverse pathological featuresClinical Radiology, 2013
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesNature, 2012
- Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaborationBMC Medicine, 2012
- Diffusion‐weighted magnetic resonance imaging of pancreatic adenocarcinomas: Association with histopathology and tumor gradeJournal of Magnetic Resonance Imaging, 2010
- Stromal biology and therapy in pancreatic cancerGut, 2010
- Pancreatic CancerNew England Journal of Medicine, 2010
- Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traitsNature Reviews Cancer, 2009
- Apparent diffusion coefficient in pancreatic cancer: Characterization and histopathological correlationsJournal of Magnetic Resonance Imaging, 2008
- Absence of E-Cadherin Expression Distinguishes Noncohesive from Cohesive Pancreatic CancerClinical Cancer Research, 2008
- Tumor-stroma interactions in pancreatic ductal adenocarcinomaMolecular Cancer Therapeutics, 2007